Cicatricial Alopecia Research Foundation Meeting, May 2016: Progress Towards the Diagnosis, Treatment, and Cure of Primary Cicatricial Alopecias

    January 2018 in “ Experimental Dermatology
    John P. Sundberg, Maria Hordinsky, Wilma F. Bergfeld, Yolanda M. Lenzy, Amy J. McMichael, Angela M. Christiano, Tracy L. McGregor, Kurt S. Stenn, Raja K Sivamani, C. Herbert Pratt, Lloyd E. King
    Image of study
    TLDR The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.
    The Cicatricial Alopecia Research Foundation meeting in May 2016 addressed primary cicatricial alopecias (PCAs), diseases causing irreversible hair follicle destruction and scarring. Over 100 attendees reviewed current knowledge and set research priorities, focusing on lichen planopilaris (LPP), frontal fibrosing alopecia (FFA), and central centrifugal cicatricial alopecia (CCCA). The report emphasized the challenges in diagnosing PCAs due to scarring by the time patients seek treatment and discussed new technologies like transcriptome and lipidome analysis for understanding disease pathogenesis. It also highlighted the use of mouse models, clinicopathological correlations, dermoscopy, and biopsy in PCA research. The document noted the unknown etiopathogenesis of PCAs but suggested potential causes such as loss of immune privilege, inflammatory responses, and genetic factors. It also mentioned the use of large biorepositories for epidemiological and genetic research, including GWAS and PheWAS, and the role of sebaceous gland dysfunction in some PCAs. The meeting set research goals for standardized sample collection, gene expression studies, computational analysis for drug discovery, and microbiome studies, while acknowledging the limitations of animal models in replicating human PCAs.
    Discuss this study in the Community →

    Research cited in this study

    34 / 34 results

    Related Community Posts Join

    6 / 426 results
      If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      in Research  830 upvotes 1 year ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community Losing Hair on Dutasteride? You might have LPP

      in Research/Science  97 upvotes 7 months ago
      Men with hair loss might have lichen planopilaris (LPP), which can mimic androgenetic alopecia, leading to misdiagnosis and ineffective treatment with finasteride or dutasteride. Proper diagnosis, including biopsies, is crucial to distinguish between androgenetic alopecia and conditions like LPP.

      community You will lose hair if your prostaglandins aren't in balance

      in Research/Science  58 upvotes 7 months ago
      Prostaglandin balance affects hair loss, particularly in conditions like Lichen Planopilaris, where an imbalance can lead to hair follicle damage. Treatments mentioned include prostaglandin analogs and Pioglitazone HCL, with a focus on maintaining prostaglandin equilibrium for potential hair regrowth.

      community Can we get a reality check on PP405?

      in Research/Science  76 upvotes 2 weeks ago
      PP405 is a promising hair loss treatment that may outperform minoxidil and finasteride by reviving dormant follicles and promoting significant regrowth. Results from ongoing trials are awaited, with a potential market release between 2028-2030.

    Related Research

    8 / 8 results